Screener
Intellia Therapeutics NTLA Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Change in fair value of investments, net | 329 | 1,339 | (575) | (786) |
| Total other income, net | 6,126 | 8,741 | 10,427 | 15,219 |
| Net loss | $(106,634) | $(101,255) | $(202,865) | $(215,584) |
| Net loss per share, basic and diluted | $(0.80) | $(0.98) | $(1.61) | $(2.08) |
| Weighted average shares outstanding, basic and diluted | 133,480 | 103,732 | 126,057 | 103,617 |
| Other comprehensive loss: | ||||
| Unrealized (loss) gain on marketable securities | (790) | (404) | (2,062) | 48 |
| Comprehensive loss | $(107,424) | $(101,659) | $(204,927) | $(215,536) |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Intellia Therapeutics (NTLA) reported comprehensive income (loss), net of tax, attributable to parent of -$107.42M in Q2 2026.
- How has Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 5.7% year-over-year, from -$101.66M to -$107.42M.
- What is the long-term trend for Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a 11.1% compound annual growth rate (CAGR), from -$270.53M to -$412.27M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as foreign currency translation adjustments and unrealized gains or losses on financial instruments. It provides a comprehensive view of the company's total financial performance and changes in net worth beyond standard operating results. Investors use this to understand the broader economic impact on the company's balance sheet and total equity position.
Ask your AI about Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude